Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plasma Services Group is a globally recognized supplier of rare and specialty plasma and biological materials, particularly supporting the in vitro diagnostics (IVD) and life science industries with high-quality disease-state materials for research, development, and manufacturing. Acquired by Fujirebio in 2024, the company continues to operate actively, specializing in the collection, screening, and supply of disease-state plasma and rare biological materials for global IVD and life science partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plasma Services Group.